<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02861235</url>
  </required_header>
  <id_info>
    <org_study_id>2009-A00422-55</org_study_id>
    <nct_id>NCT02861235</nct_id>
  </id_info>
  <brief_title>Comparison Between Myocardial Tomoscintigraphies Using a Semiconductor Camera or a Conventional Camera</brief_title>
  <acronym>DSPECT</acronym>
  <official_title>Comparison Between Myocardial Tomoscintigraphies Using a Semiconductor Camera or a Conventional Camera According to Conditions of Examination Execution: Assessment of Infarction or Ischemia, Injected Dye and Sequence of Injections</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Central Hospital, Nancy, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Central Hospital, Nancy, France</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Myocardial perfusion tomoscintigraphy is a routine medicine procedure to check for the
      presence and severity of abnormalities of myocardial perfusion, as well as the extension of
      infarction residua. However, actual imagery devices (gamma cameras) have low resolution and
      detection sensitivity. A new semiconductor camera has 8 to 10 time higher detection
      sensitivity and could allow proportionally diminishing injected activities or recording
      times. Only one pilot study has been recently published on this type of camera, the D.SPECT
      camera.

      This study will compare images recorded during 15 to 20 minutes by conventional cameras and 2
      to 4 minutes by D.SPECT camera in patients doing tomoscintigraphy under usual conditions. The
      purpose is to demonstrate the equivalence of images recorded by two camera types for
      diagnostic information and the secondary purpose is to demonstrate the superiority of the
      D.SPECT camera in terms of image quality.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study will be conducted in Nuclear Medicine departments (Nancy Hospital, Bichat Hospital
      in Paris, Pasteur private hospital in Toulouse), with D.SPECT camera (Cyclopharma). The
      D.SPECT camera recording will be realized following the conventional camera recording and
      will not modify the routine programmed examination. Recording times of D.SPECT camera will be
      maximum 2 minutes for imaging with a strong activity of technetium-99m labeled dye and
      maximum 4 minutes for imaging with thallium-201 or with a low activity of technetium-99m
      labeled dye.6 study groups will be analyzed: 4 groups of patients initially doing stress
      tomoscintigraphy with thallium-201 (group 1) or with technetium-99m labeled dye and then
      testing 3 principal injection sequences (group 2, 3, 4), and 2 groups of patients initially
      doing &quot;myocardial viability&quot; assessment with rest tomoscintigraphy with thallium-201 (group
      5) or technetium-99m labeled dye.

      Recording comparison obtained with 2 cameras will be done according to qualitative and
      quantitative criteria on image quality and analyzing diagnosis concordance (presence, type
      and severity of observed abnormalities).
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2009</start_date>
  <completion_date type="Actual">May 2010</completion_date>
  <primary_completion_date type="Actual">May 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Ejection fraction of link ventricle</measure>
    <time_frame>day 0</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Telesystolic volume of link ventricle</measure>
    <time_frame>day 0</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Telediastolic volume of link ventricle</measure>
    <time_frame>day 0</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Diagnosis of stress ischemia with Myocardial Tomoscintigraphy data</measure>
    <time_frame>day 0</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Area of damaged regions of heart</measure>
    <time_frame>day 0</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Global myocardial activity</measure>
    <time_frame>day 0</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Qualitative score of image quality</measure>
    <time_frame>day 0</time_frame>
  </secondary_outcome>
  <number_of_arms>6</number_of_arms>
  <enrollment type="Actual">276</enrollment>
  <condition>Myocardial Infarction</condition>
  <condition>Ischemia</condition>
  <arm_group>
    <arm_group_label>1. stress thallium-201 tomoscintigraphy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>2. stress technetium-99m tomoscintigraphy 1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>3. stress technetium-99m tomoscintigraphy 2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>4. stress technetium-99m tomoscintigraphy 3</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>5. rest thallium-201 tomoscintigraphy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>6. rest technetium-99m tomoscintigraphy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Stress thallium-201 tomoscintigraphy, followed by a second rest tomoscintigraphy if necessary</intervention_name>
    <description>with gamma-camera and D.SPECT camera</description>
    <arm_group_label>1. stress thallium-201 tomoscintigraphy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Rest technetium-99m tomoscintigraphy followed by stress technetium-99m tomoscintigraphy on the same day</intervention_name>
    <description>with gamma-camera and D.SPECT camera, in Toulouse centre</description>
    <arm_group_label>2. stress technetium-99m tomoscintigraphy 1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Stress technetium-99m tomoscintigraphy followed by rest technetium-99m tomoscintigraphy on the same day</intervention_name>
    <description>with gamma-camera and D.SPECT camera, in Nancy centre</description>
    <arm_group_label>3. stress technetium-99m tomoscintigraphy 2</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>stress technetium-99m tomoscintigraphy followed by rest technetium-99m tomoscintigraphy in two different days</intervention_name>
    <description>with gamma-camera and D.SPECT camera, in Paris centre</description>
    <arm_group_label>4. stress technetium-99m tomoscintigraphy 3</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Rest thallium-201 tomoscintigraphy with gamma-camera and D.SPECT camera</intervention_name>
    <description>rest thallium-201 tomoscintigraphy for myocardial viability assessment</description>
    <arm_group_label>5. rest thallium-201 tomoscintigraphy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Rest technetium-99m tomoscintigraphy with gamma-camera and D.SPECT camera</intervention_name>
    <description>rest technetium-99m tomoscintigraphy for myocardial viability assessment</description>
    <arm_group_label>6. rest technetium-99m tomoscintigraphy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Understanding and signature of informed consent

          -  Without any contraindication for tomoscintigraphy and stress techniques according to
             French Society of Cardiology and Nuclear Medicine criteria, as established for all
             patients doing this routine examination

          -  Not in emergency situation and with a stable clinical status (without any sign of
             heart or coronary failure, without uncontrolled high blood pressure under treatment)

          -  Having an effective contraception for women of childbearing potential

        Exclusion Criteria:

          -  Patient under guardianship
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Wassilia DJABALLAH</last_name>
    <role>Principal Investigator</role>
    <affiliation>Service de Médecine Nucléaire, Hôpital de Brabois, 54500, Vandoeuvre-les-Nancy, France</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Service de Médecine Nucléaire, Hôpital de Bichat, Assistance Publique des Hôpitaux de Paris</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Service de Médecine Nucléaire, Clinique Louis Pasteur</name>
      <address>
        <city>Toulouse</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Service de Médecine Nucléaire, Hôpital de Brabois, CHU de Nancy</name>
      <address>
        <city>Vandoeuvre-les-Nancy</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>August 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 29, 2016</study_first_submitted>
  <study_first_submitted_qc>August 5, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 10, 2016</study_first_posted>
  <last_update_submitted>August 5, 2016</last_update_submitted>
  <last_update_submitted_qc>August 5, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 10, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infarction</mesh_term>
    <mesh_term>Myocardial Infarction</mesh_term>
    <mesh_term>Ischemia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

